HOME › DRUGS › TRASTUZUMAB DERUXTECAN
ACTIVE SUBSTANCE / INN

TRASTUZUMAB DERUXTECAN

Brand name(s): Enhertu
EMA LISTED
AUTHORISED
Breast Neoplasms
ACTIVE SUBSTANCE
Trastuzumab Deruxtecan
REGULATORS
EMA
SPONSORS / MAH
Daiichi Sankyo Europe GmbH
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EnhertuDaiichi Sankyo Europe GmbHAuthorised18/01/2021Breast Neoplasms

FULL INTELLIGENCE ON TRASTUZUMAB DERUXTECAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →